Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. (Q51902268)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

visceral leishmaniasis

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Ahmed Mudawi Musa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Fawzi Abd Elrahim Mahgoub

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sara Hamad Hassab Elgawi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Farroukh Modabber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Abd Elgadir Mohamed Yousif Elkadaru

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mona Hussein Aboud

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sassan Noazin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hashim Warsama Ghalib

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ahmed Mohamed El-Hassan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Leishmaniasis Research Group/Sudan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

25 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

Transactions of the Royal Society of Tropical Medicine and Hygiene

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

58-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17963805%20AND%20SRC:MED&resulttype=core&format=json

Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Vaccine for prophylaxis and immunotherapy, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Dichotomy of protective cellular immune responses to human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Leishmanin test in post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Editorial: Measurement of delayed skin-test responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Post-kala-azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: Does ultraviolet light (UVB) radiation play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Post kala-azar ocular leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006

Laryngeal involvement during post kala-azar dermal leishmaniasis in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.08.006